Lannett Co. Inc.

Lannett Co. Inc.
Stock Exchange New York Stock Exchange
EPS
$7.36
Market Cap
$237.12 M
Shares Outstanding
39.32 M
Public Float
27.81 M

Profile

Address
9000 State Road
Philadelphia Pennsylvania 19136
United States
Employees -
Website http://www.lannett.com
Updated 07/08/2019
Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escltalopram oxalate; renitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.

Financials

View All

Patrick G. LePore
Chairman
Timothy C. Crew
Chief Executive Officer & Director